News

Adverum Biotechnologies announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to ADVM-053, a preclinical gene therapy candidate…
Read More...

JW Pharmaceutical and LEO Pharma A/S announced that they have signed a global licensing agreement for JWP’s novel atopic dermatitis drug candidate, JW1601, under which, LEO Pharma, a…
Read More...

Tolero Pharmaceuticals has entered into a clinical research collaboration with AbbVie, a research-based global biopharmaceutical company, exploring the potential of combination therapy…
Read More...

Roche announced that the China National Drug Administration (CNDA) has granted marketing authorisation for Alecensa (alectinib) as a monotherapy treatment for patients with anaplastic…
Read More...

AstraZeneca announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) has approved Tagrisso(osimertinib) for the 1st-line treatment of patients with inoperable or…
Read More...

Innovate Biopharmaceuticals announced it signed an agreement with Amarex Clinical Research to provide data management and biostatistics for its planned Phase 3 celiac disease trial.…
Read More...

PTC Therapeutics announced that it has successfully completed the acquisition of Agilis Biotherapeutics, Inc., a private biotechnology company focused on the advancement of innovative…
Read More...

bluebird bio and Gritstone Oncology announced a collaboration to research, develop and commercialize products for the treatment of cancer using cell therapy. Gritstone Oncology will…
Read More...

AGC Biologics announced that as part of its global expansion strategy, the company is increasing manufacturing capacity at its Copenhagen, Denmark facility. The Copenhagen facility…
Read More...

The U.S. Food and Drug Administration approved the first drug, Oxervate (cenegermin), for the treatment of neurotrophic keratitis, a rare disease affecting the cornea (the clear layer…
Read More...

Revive Therapeutics Ltd. announced that it has submitted an application to the U.S. Food and Drug Administration seeking orphan drug designation of cannabidiol for the treatment of…
Read More...

Almac Group has announced the appointment of Jonothan Cooil to Vice President of Engineering, Facilities and Health, Safety & Environment. He will report to Almac Group CEO, Alan…
Read More...

Structured Immunity and Medigene announced a research collaboration where Structured Immunity will provide structural immunology expertise in support of Medigene's TCR discovery…
Read More...

Boehringer Ingelheim held a groundbreaking ceremony for the construction of a new production facility for innovative drugs. This new Solids Launch facility will focus on development…
Read More...

Immune Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation (ODD) to bertilimumab for the treatment of bullous pemphigoid (BP).…
Read More...

The Centre for the Commercialization of Antibodies and Biologics (CCAB) and ImmunoBiochem Corporation have announced an agreement that will see CCAB provide a new investment to help…
Read More...

Enigma Biomedical Group (EBG) announced a collaboration agreement with Invicro, a Konica Minolta Company and a leading provider of imaging services and software for research and drug…
Read More...

Regeneron Pharmaceuticals, Inc. and Teva Pharmaceutical Industries Ltd. announced positive topline results from a Phase 3, randomized, double-blind, placebo-controlled study of…
Read More...

Sun Pharmaceutical Industries Ltd. announced that Sun Pharma has received approval for CEQUA (cyclosporine ophthalmic solution) 0.09%, from the U.S. Food and Drug Administration (FDA).…
Read More...

Eisai Inc. and Merck, known as MSD outside of the United States and Canada, announced today that the U.S. Food and Drug Administration (FDA) approved the kinase inhibitor LENVIMA …
Read More...